Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details)

v3.22.2.2
Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Liabilities:    
Private warrants $ 3,093 $ 19,098
Contingent consideration 1,000 1,000
Fair Value, Recurring    
Assets:    
Committed equity facility 616  
Total assets 616  
Liabilities:    
Private warrants 3,093 19,098
Contingent consideration 1,000 1,000
Total liabilities 4,093 20,098
Level 1 | Fair Value, Recurring    
Assets:    
Committed equity facility 0  
Total assets 0  
Liabilities:    
Private warrants 0 0
Contingent consideration 0 0
Total liabilities 0 0
Level 2 | Fair Value, Recurring    
Assets:    
Committed equity facility 0  
Total assets 0  
Liabilities:    
Private warrants 0 0
Contingent consideration 0 0
Total liabilities 0 0
Level 3 | Fair Value, Recurring    
Assets:    
Committed equity facility 616  
Total assets 616  
Liabilities:    
Private warrants 3,093 19,098
Contingent consideration 1,000 1,000
Total liabilities $ 4,093 $ 20,098